Nikolaienko, Oleksii
Anderson, Garnet L.
Chlebowski, Rowan T.
Jung, Su Yon
Harris, Holly R.
Knappskog, Stian
Lønning, Per E.
Funding for this research was provided by:
National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services
Kreftforeningen
Norges Forskningsråd
SKG Jebsen Foundation
Helseregion Vest
University of Bergen
Article History
Received: 10 December 2024
Accepted: 6 February 2025
First Online: 20 February 2025
Declarations
:
: The study was approved by the Norwegian Region North Ethical Committee; ref no 241802.
: Dr Lønning has received speaker’s honoraria from Illumina. Dr. Knappskog has received research funding for other projects from AstraZeneca, Pfizer, and Illumina, and speaker’s bureaux honoraria from AstraZeneca, Pfizer, Pierre Fabre, and Novartis. Dr Chlebowski is a consultant for Pfizer and UpToDate. No other author reported conflicts of interest.